Newsletter | July 9, 2024

07.09.24 -- EMA Updates Guidance On Inhalation And Nasal Product Quality

FEATURED EDITORIAL

EMA Updates Guidance On Inhalation And Nasal Product Quality

The EMA has issued a new draft guideline, “Guideline On The Pharmaceutical Quality Of Inhalation And Nasal Medicinal Products.” The public comment period ends Oct. 31.

Periodontitis And Neurological Disease: New Insights For Drug Targeting

This article discusses the link between periodontal disease and systemic disorders, focusing most on the association between proteases and neurological dysfunction. Therapeutic measures can target these pathological pathways.

MOST POPULAR NEWS

Quest Diagnostics To Acquire Lifelabs From OMERS

Thermo Fisher Scientific Expands Clinical Research Laboratory In Kentucky

SGS North America Announces Expansion Of Biologics Testing Capabilities

Trudiagnostic Launches First Ever Organ-Specific Aging Analysis

CMS Awards Tempus With ADLT Status For Its xT CDx Test

MLM Medical Labs Poised For Growth With Facilities Expansion

Anacura Acquires OHMX.bio, Adding Multi-Omics To Its Services

Immunovia's New Lab Staffed And Operational After Rapid Implementation

New Lab Test To Detect Persistent HIV Strains In Africa May Aid Search For Cure

FDA Permits Marketing Of First Point-Of-Care Hepatitis C RNA Test

Anbio Biotechnology To Showcase In Vitro Diagnostic Solutions At ADLM 2024